MOTS-c 10mg – PharmaTech

MOTS-c (Mitochondrial Open Reading Frame of the 12S rRNA-c) is a naturally occurring 16-amino-acid mitochondrial-derived peptide (MDP) encoded by a short open reading frame within mitochondrial DNA.

Unlike conventional peptides encoded by nuclear genes, MOTS-c represents a mitochondrial signaling molecule involved in communication between mitochondrial metabolism, cellular energy sensing, and nuclear gene regulation. Experimental research has associated MOTS-c with metabolic homeostasis, insulin sensitivity, cellular stress adaptation, mitochondrial bioenergetics, and exercise-related signaling.

MOTS-c is particularly relevant to research investigating the relationship between mitochondrial function, AMPK signaling, metabolic flexibility, oxidative stress, and cellular adaptation.

OVERVIEW

MOTS-c (Mitochondrial Open Reading Frame of the 12S rRNA-c) is a naturally occurring 16-amino-acid mitochondrial-derived peptide (MDP) encoded by a short open reading frame within mitochondrial DNA.

Unlike conventional peptides encoded by nuclear genes, MOTS-c represents a mitochondrial signaling molecule involved in communication between mitochondrial metabolism, cellular energy sensing, and nuclear gene regulation. Experimental research has associated MOTS-c with metabolic homeostasis, insulin sensitivity, cellular stress adaptation, mitochondrial bioenergetics, and exercise-related signaling.

MOTS-c is particularly relevant to research investigating the relationship between mitochondrial function, AMPK signaling, metabolic flexibility, oxidative stress, and cellular adaptation.


MECHANISM OF ACTION

AMPK & Energy-Sensing Signaling

One of the principal pathways associated with MOTS-c is the AMP-activated protein kinase (AMPK) system.

Experimental research indicates that MOTS-c can influence the folate cycle and de novo purine biosynthesis, increasing intracellular AICAR-related signaling and contributing to AMPK activation. AMPK functions as a major cellular energy sensor regulating glucose utilization, fatty-acid metabolism, and energy homeostasis.

Mitochondria–Nucleus Communication

MOTS-c can translocate from the cytoplasm into the nucleus under metabolic stress.

Within the nucleus, experimental studies have shown that MOTS-c can influence stress-responsive gene expression through an AMPK-dependent mechanism, including interaction with transcriptional pathways associated with antioxidant response elements and NRF2-related signaling.

Mitochondrial Bioenergetics

More recent experimental work has investigated MOTS-c in skeletal-muscle mitochondrial function, with findings linking its activity to AMPK and PGC-1α-dependent pathways involved in mitochondrial bioenergetic performance.

Metabolic Regulation

Research models have associated MOTS-c with:

  • Glucose utilization
  • Insulin sensitivity
  • Fatty-acid oxidation
  • Energy expenditure
  • Metabolic adaptation
  • Mitochondrial efficiency
  • Cellular stress responses

KEY BENEFITS

Research interest in MOTS-c includes:

  • Mitochondrial metabolism
  • Cellular energy homeostasis
  • AMPK signaling
  • Insulin-sensitivity research
  • Glucose metabolism
  • Fatty-acid oxidation
  • Metabolic flexibility
  • Mitochondrial bioenergetics
  • Skeletal-muscle metabolism
  • Exercise-associated signaling
  • Oxidative-stress research
  • Cellular stress adaptation
  • Aging and longevity biology
  • Mitochondria–nucleus communication

These represent research areas associated with MOTS-c biology and should not be interpreted as established therapeutic outcomes.


RESEARCH AREAS

Mitochondrial Biology

MOTS-c is particularly relevant to studies investigating how mitochondria function not only as energy-producing organelles but also as sources of regulatory signaling peptides.

AMPK Signaling

Research into MOTS-c provides a model for studying cellular energy sensing through AMPK and associated metabolic pathways.

Glucose & Insulin Signaling

Preclinical studies have investigated MOTS-c in relation to glucose metabolism, insulin sensitivity, and metabolic homeostasis.

Fatty-Acid Oxidation

Experimental research has associated MOTS-c with increased fatty-acid oxidation and alterations in metabolic pathways associated with lipid utilization.

Skeletal-Muscle Metabolism

MOTS-c has been investigated in skeletal muscle as a regulator of mitochondrial bioenergetics and metabolic adaptation, including pathways involving AMPK and PGC-1α.

Cellular Stress Response

MOTS-c can participate in mitochondrial-to-nuclear signaling under metabolic stress and has been investigated in relation to antioxidant response pathways.

Aging & Longevity Biology

MOTS-c is an active area of research into mitochondrial signaling, cellular senescence, metabolic aging, and age-associated metabolic dysfunction. Recent experimental work has also investigated MOTS-c in pancreatic islet-cell senescence.


SCIENTIFIC EVIDENCE

The original characterization of MOTS-c identified it as a 16-amino-acid peptide encoded by mitochondrial 12S rRNA and demonstrated effects on metabolic homeostasis and insulin sensitivity in experimental models. In mice, MOTS-c treatment was associated with protection against diet-induced metabolic dysfunction and increased AMPK-related signaling.

Subsequent research demonstrated that MOTS-c can translocate to the nucleus under metabolic stress and influence nuclear gene expression through AMPK-dependent mechanisms, including regulation of genes associated with antioxidant response elements.

Additional experimental studies have investigated MOTS-c in skeletal-muscle mitochondrial bioenergetics, reporting involvement of AMPK and PGC-1α pathways.

Human research remains considerably more limited than the preclinical literature. Observational studies have investigated circulating MOTS-c concentrations in relation to insulin sensitivity, while more recent work continues to explore its relationship with metabolic disease and cellular aging.

Accordingly, the strongest current evidence base for MOTS-c remains mechanistic and preclinical, with human pharmacological and therapeutic characterization still developing.


MOLECULAR PROFILE

Parameter MOTS-c
Full name Mitochondrial Open Reading Frame of the 12S rRNA-c
Compound class Mitochondrial-derived peptide
Peptide length 16 amino acids
Sequence MRWQEMGYIFYPRKLR
Molecular formula C₁₀₁H₁₅₂N₂₈O₂₂S₂
Molecular weight ~2,174.6 Da
CAS 1627580-64-6
Genetic origin Mitochondrial DNA
Source region 12S rRNA short open reading frame
Primary research pathways AMPK / PGC-1α / metabolic stress signaling
Cellular distribution Cytoplasmic and nuclear under metabolic stress
Molecular category Mitochondrial signaling peptide

The human MOTS-c sequence and molecular characteristics are documented as MRWQEMGYIFYPRKLR, with a calculated molecular weight of approximately 2.17 kDa.


PHARMACOKINETIC & PHARMACODYNAMIC PROFILE

Pharmacokinetic Profile

Comprehensive human pharmacokinetic characterization of exogenously administered MOTS-c remains limited.

The pharmacokinetic behavior of the peptide can be influenced by:

  • Peptide stability
  • Proteolytic degradation
  • Formulation
  • Concentration
  • Route of administration
  • Chemical form or counterion
  • Tissue distribution
  • Clearance mechanisms

Consequently, pharmacokinetic parameters for a specific PharmaTech formulation should be established through product-specific analytical and pharmacological characterization.

Pharmacodynamic Profile

The principal experimental signaling cascade can be summarized as:

MOTS-c → metabolic stress sensing → AMPK-related signaling → energy metabolism

Additional pathways include:

MOTS-c → folate/purine metabolism → AICAR-related signaling → AMPK activation

and:

MOTS-c → cellular stress → nuclear translocation → NRF2/ARE-associated gene regulation

In skeletal muscle:

MOTS-c → AMPK / PGC-1α signaling → mitochondrial bioenergetic adaptation.

This places MOTS-c within a broader network connecting mitochondrial metabolism, cellular energy sensing, and nuclear stress-response mechanisms.


RESEARCH HIGHLIGHTS

  • Mitochondrial-derived signaling peptide
  • 16-amino-acid mitochondrial peptide
  • AMPK pathway research
  • Mitochondria–nucleus communication
  • Cellular energy sensing
  • Glucose and insulin signaling
  • Fatty-acid oxidation
  • Mitochondrial bioenergetics
  • Skeletal-muscle metabolism
  • PGC-1α-associated pathways
  • Oxidative-stress research
  • NRF2/ARE-related signaling
  • Metabolic adaptation
  • Aging and cellular-senescence research

TECHNICAL SPECIFICATIONS

Parameter PharmaTech Specification
Product MOTS-c
Product type Synthetic mitochondrial-derived peptide
Peptide length 16 amino acids
Sequence MRWQEMGYIFYPRKLR
Molecular weight ~2.17 kDa
Total quantity [PharmaTech specification]
Purity ≥ [PharmaTech specification]%
Physical form Lyophilized powder
Appearance White to off-white lyophilized material
Chemical form [PharmaTech specification]
Batch [Batch specification]
Storage Controlled refrigerated storage
Research category Mitochondrial / metabolic signaling

STORAGE & HANDLING

Store the lyophilized product under controlled conditions according to the applicable PharmaTech product specification.

Protect from:

  • Excessive heat
  • Direct light
  • Moisture
  • Repeated temperature fluctuations
  • Physical contamination

Maintain the container sealed until laboratory use and handle under appropriate controlled conditions.